Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-098796
Filing Date
2025-10-10
Accepted
2025-10-10 17:28:47
Documents
23
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2528273d1_6k.htm 6-K 11497
2 EXHIBIT 99.1 tm2528273d1_ex99-1.htm EX-99.1 41370
3 GRAPHIC tm2528273d1_ex99-1img001.jpg GRAPHIC 84300
4 GRAPHIC tm2528273d1_ex99-1img002.jpg GRAPHIC 238701
5 GRAPHIC tm2528273d1_ex99-1img003.jpg GRAPHIC 147797
6 GRAPHIC tm2528273d1_ex99-1img004.jpg GRAPHIC 212394
7 GRAPHIC tm2528273d1_ex99-1img005.jpg GRAPHIC 133693
8 GRAPHIC tm2528273d1_ex99-1img006.jpg GRAPHIC 152920
9 GRAPHIC tm2528273d1_ex99-1img007.jpg GRAPHIC 183036
10 GRAPHIC tm2528273d1_ex99-1img008.jpg GRAPHIC 62436
11 GRAPHIC tm2528273d1_ex99-1img009.jpg GRAPHIC 183002
12 GRAPHIC tm2528273d1_ex99-1img010.jpg GRAPHIC 147929
13 GRAPHIC tm2528273d1_ex99-1img011.jpg GRAPHIC 175632
14 GRAPHIC tm2528273d1_ex99-1img012.jpg GRAPHIC 137170
15 GRAPHIC tm2528273d1_ex99-1img013.jpg GRAPHIC 165250
16 GRAPHIC tm2528273d1_ex99-1img014.jpg GRAPHIC 168880
17 GRAPHIC tm2528273d1_ex99-1img015.jpg GRAPHIC 187852
18 GRAPHIC tm2528273d1_ex99-1img016.jpg GRAPHIC 167067
19 GRAPHIC tm2528273d1_ex99-1img017.jpg GRAPHIC 109807
20 GRAPHIC tm2528273d1_ex99-1img018.jpg GRAPHIC 70115
21 GRAPHIC tm2528273d1_ex99-1img019.jpg GRAPHIC 180132
22 GRAPHIC tm2528273d1_ex99-1img020.jpg GRAPHIC 134227
23 GRAPHIC tm2528273d1_ex99-1img021.jpg GRAPHIC 170596
  Complete submission text file 0001104659-25-098796.txt   4465194
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 251388827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)